The effect of differentiating and apoptotic agents on notch signalling pathway in hepatoblastoma.
Aktaş
Safiye
S
Dokuz Eylul University Institute of Oncology, Izmir Turkey. safiyeaktas@yahoo.com
Zadeoğlulari
Zeynep
Z
Erçetin
Pinar
P
Olgun
Nur
N
D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D001374:Azacitidine / Q000031:analogs & derivatives / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D002945:Cisplatin / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D019175:DNA Methylation; D000077209:Decitabine; D004317:Doxorubicin / Q000494:pharmacology; D020869:Gene Expression Profiling; D056945:Hep G2 Cells; D018197:Hepatoblastoma / Q000378:metabolism*; D006801:Humans; D015474:Isotretinoin / Q000494:pharmacology; D008113:Liver Neoplasms / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D051880:Receptors, Notch / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects*; D013723:Teratogens / Q000494:pharmacology
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D051880:Receptors, Notch; D013723:Teratogens; D003561:Cytarabine; D000077209:Decitabine; D004317:Doxorubicin; D015474:Isotretinoin; D001374:Azacitidine; D002945:Cisplatin